Literature DB >> 26300346

Analysis of proliferation and apoptotic induction by 20 steroid glycosides in 143B osteosarcoma cells in vitro.

C I Delebinski1, S Georgi2, S Kleinsimon1, M Twardziok1, B Kopp3, M F Melzig2, G Seifert1.   

Abstract

OBJECTIVES: Osteosarcoma is the most common type of malignant bone tumour in children and adolescents; it has poor prognosis, is highly metastatic and is resistant to current therapeutic approaches. In this study, different herbal extracts used in phytotherapy have been screened after searching innovative natural anti-cancer components.
MATERIALS AND METHODS: Twenty steroid glycosides were examined for accordance to their potential of inhibiting cell proliferation and inducing apoptosis in the osteosarcoma cell line 143B. Cell proliferation was examined using a CASY counter. Effects of cardiac glycosides on induction of apoptosis were evaluated by Annexin V-APC and flow cytometry, caspase activity assay and measurement of mitochondrial membrane potential.
RESULTS: The study revealed that various steroid glycosides suppress cell proliferation in a concentration-dependent manner. Further investigations indicated apoptotic induction by 17 of the 20 tested cardenolides and bufadienolides. Bufadienolide proscillaridin A, arenobufagin, and cardenolides evomonoside, convallatoxol and ouabain waged strongest apoptotic induction, associated with breakdown of mitochondrial membrane potential and activation of caspases -8 and -9. In contrast, the bufadienolide resibufogenin and cardenolide uzarin had no effect on proliferation inhibition, apoptotic induction or change in mitochondrial membrane potential.
CONCLUSION: These results indicate that bufadienolides proscillaridin A and arenobufagin and cardenolide evomonoside, or related natural compounds might be promising new starting points for development of novel anti-cancer agents for treatment of osteosarcoma.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26300346      PMCID: PMC6496835          DOI: 10.1111/cpr.12208

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  74 in total

1.  Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A.

Authors:  Krzysztof Bielawski; Katarzyna Winnicka; Anna Bielawska
Journal:  Biol Pharm Bull       Date:  2006-07       Impact factor: 2.233

2.  Rapid structural identification of cytotoxic bufadienolide sulfates in toad venom from Bufo melanosticus by LC-DAD-MS(n) and LC-SPE-NMR.

Authors:  Huimin Gao; Martin Zehl; Hanspeter Kaehlig; Peter Schneider; Hermann Stuppner; Laetitia Moreno Y Banuls; Robert Kiss; Brigitte Kopp
Journal:  J Nat Prod       Date:  2010-04-23       Impact factor: 4.050

3.  Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine.

Authors:  Anne Mahringer; Shirin Karamustafa; Daniel Klotz; Stefan Kahl; V Badireenath Konkimalla; Yifen Wang; Junsong Wang; Hai-Yang Liu; Herbert Boechzelt; Xiaojiang Hao; Rudolf Bauer; Gert Fricker; Thomas Efferth
Journal:  Cancer Genomics Proteomics       Date:  2010 Jul-Aug       Impact factor: 4.069

4.  Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.

Authors:  Jun-Qiang Yin; Jing-Nan Shen; Wei-Wei Su; Jin Wang; Gang Huang; Song Jin; Qian-Chen Guo; Chang-Ye Zou; Hao-Miao Li; Fo-Bao Li
Journal:  Acta Pharmacol Sin       Date:  2007-05       Impact factor: 6.150

5.  Reevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na⁺/K⁺-ATPase α3 subunit-involved mitochondrial stress and amplification of caspase cascades.

Authors:  She-Hung Chan; Wohn-Jenn Leu; Lih-Ching Hsu; Hsun-Shuo Chang; Tsong-Long Hwang; Ih-Sheng Chen; Ching-Shih Chen; Jih-Hwa Guh
Journal:  Biochem Pharmacol       Date:  2013-10-04       Impact factor: 5.858

6.  Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway.

Authors:  Dewei Wang; Zhenggang Bi
Journal:  Tumour Biol       Date:  2014-02-26

7.  Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells.

Authors:  Katarzyna Winnicka; Krzysztof Bielawski; Anna Bielawska; Wojciech Miltyk
Journal:  Arch Pharm Res       Date:  2007-10       Impact factor: 4.946

8.  Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.

Authors:  Ching-Han Yu; Shu-Fen Kan; Hsiao-Fung Pu; Eileen Jea Chien; Paulus S Wang
Journal:  Cancer Sci       Date:  2008-11-26       Impact factor: 6.716

9.  The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cells.

Authors:  Tatjana Mijatovic; Ute Jungwirth; Petra Heffeter; Mir Ali Reza Hoda; Rita Dornetshuber; Robert Kiss; Walter Berger
Journal:  Cancer Lett       Date:  2009-03-31       Impact factor: 8.679

10.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

View more
  12 in total

1.  MicroRNA-665 suppressed the invasion and metastasis of osteosarcoma by directly inhibiting RAB23.

Authors:  Chenhui Dong; Quanyin Du; Zimin Wang; Yu Wang; Siyu Wu; Aimin Wang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

2.  NOVA1 acts as an oncogene in osteosarcoma.

Authors:  Chengzhen Li; Ying He; Haijing Ma; Seongho Han
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

3.  LncRNA BCRT1 facilitates osteosarcoma progression via regulating miR-1303/FGF7 axis.

Authors:  Gang Han; Quanyi Guo; Ning Ma; Wenzhi Bi; Meng Xu; Jinpeng Jia; Wei Wang
Journal:  Aging (Albany NY)       Date:  2021-06-08       Impact factor: 5.682

4.  MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression.

Authors:  Chi Jin; Yongjian Feng; Yongjian Ni; Zhonglin Shan
Journal:  Oncotarget       Date:  2017-04-11

5.  MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.

Authors:  Xiangkun Wu; Lihua Yan; Yongxi Liu; Wenfeng Xian; Liuyu Wang; Xunmeng Ding
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

6.  LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion.

Authors:  Lihua Yan; Xiangkun Wu; Xianzhe Yin; Feng Du; Yongxi Liu; Xunmeng Ding
Journal:  J Cell Mol Med       Date:  2018-03-04       Impact factor: 5.310

7.  Suppression of mRNA Nanoparticle Transfection in Human Fibroblasts by Selected Interferon Inhibiting Small Molecule Compounds.

Authors:  Yang Liu; Manoj N Krishnan; Kyle K L Phua
Journal:  Biomolecules       Date:  2017-07-31

8.  Antiplasmodial and Cytotoxic Activities of Toad Venoms from Southern Amazon, Brazil.

Authors:  Felipe Finger Banfi; Karla de Sena Guedes; Carla Regina Andrighetti; Ana Carolina Aguiar; Bryan Wender Debiasi; Janaina da Costa Noronha; Domingos de Jesus Rodrigues; Gerardo Magela Vieira Júnior; Bruno Antonio Marinho Sanchez
Journal:  Korean J Parasitol       Date:  2016-08-31       Impact factor: 1.341

9.  A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype.

Authors:  Smitha Kota; Shurong Hou; William Guerrant; Franck Madoux; Scott Troutman; Virneliz Fernandez-Vega; Nina Alekseeva; Neeharika Madala; Louis Scampavia; Joseph Kissil; Timothy P Spicer
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

10.  LncRNA HIF1A-AS2 promotes osteosarcoma progression by acting as a sponge of miR-129-5p.

Authors:  Xuesong Wang; Lei Peng; Xiaojin Gong; Xiugong Zhang; Ruifu Sun
Journal:  Aging (Albany NY)       Date:  2019-12-22       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.